iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company is headquartered in San Francisco, California.
| Revenue (TTM) | $787.85M |
| Gross Profit (TTM) | $559.39M |
| EBITDA | $-11.16M |
| Operating Margin | -5.95% |
| Return on Equity | -22.40% |
| Return on Assets | -1.15% |
| Revenue/Share (TTM) | $24.44 |
| Book Value | $4.73 |
| Price-to-Book | 24.63 |
| Price-to-Sales (TTM) | 4.97 |
| EV/Revenue | 5.27 |
| EV/EBITDA | 329.97 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.70% |
| Shares Outstanding | $32.86M |
| Float | $30.82M |
| % Insiders | 1.22% |
| % Institutions | 113.16% |
Volatility is currently expanding